GA
GFS Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Hold |
16,094
| – | – | 0.18% | 80 |
|
|
2025
Q1 | $1.31M | Sell |
16,094
-1,612
| -9% | -$131K | 0.26% | 64 |
|
|
2024
Q4 | $1.6M | Sell |
17,706
-1,251
| -7% | -$113K | 0.24% | 68 |
|
|
2024
Q3 | $1.87M | Buy |
18,957
+17,617
| +1,315% | +$1.74M | 0.4% | 45 |
|
|
2024
Q2 | $1.78M | Sell |
1,340
-16,842
| -93% | -$22.4M | 0.29% | 65 |
|
|
2024
Q1 | $1.73M | Buy |
18,182
+5,738
| +46% | +$544K | 0.29% | 67 |
|
|
2023
Q4 | $1.11M | Sell |
12,444
-270
| -2% | -$24.1K | 0.16% | 87 |
|
|
2023
Q3 | $928K | Sell |
12,714
-91
| -0.7% | -$6.64K | 0.14% | 92 |
|
|
2023
Q2 | $1.07M | Buy |
12,805
+4
| +0% | +$333 | 0.24% | 73 |
|
|
2023
Q1 | $976K | Sell |
12,801
-125
| -1% | -$9.53K | 0.22% | 78 |
|
|
2022
Q4 | $1.07M | Buy |
12,926
+21
| +0.2% | +$1.74K | 0.24% | 72 |
|
|
2022
Q3 | $1.02M | Sell |
12,905
-108
| -0.8% | -$8.57K | 0.25% | 73 |
|
|
2022
Q2 | $966K | Sell |
13,013
-1,802
| -12% | -$134K | 0.22% | 75 |
|
|
2022
Q1 | $1.33M | Buy |
14,815
+2,434
| +20% | +$219K | 0.28% | 69 |
|
|
2021
Q4 | $1.39M | Buy |
12,381
+494
| +4% | +$55.3K | 0.23% | 77 |
|
|
2021
Q3 | $1.49M | Buy |
11,887
+1,811
| +18% | +$228K | 0.32% | 67 |
|
|
2021
Q2 | $1.36M | Buy |
10,076
+1,741
| +21% | +$236K | 0.31% | 69 |
|
|
2021
Q1 | $1.13M | Buy |
8,335
+1,459
| +21% | +$198K | 0.26% | 66 |
|
|
2020
Q4 | $968K | Buy |
6,876
+831
| +14% | +$117K | 0.25% | 70 |
|
|
2020
Q3 | $674K | Buy |
+6,045
| New | +$674K | 0.21% | 71 |
|